No Data
No Data
HDL Therapeutics to Go Public in Merger With Swiftmerge Acquisition Corp.
$480 million Business Combination to Accelerate the Commercialization of an Innovative FDA-Approved Cardiovascular Disease Treatment HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage
Swiftmerge Acquisition Corp. Shares To Resume Trade At 12:45 P.m. ET
Swiftmerge Acquisition Corp. Shares To Resume Trade At 12:45 p.m. ET
Swiftmerge Acquisition (NASDAQ:IVCPU) Stock Price Up 0.1%
Swiftmerge Acquisition Corp. (NASDAQ:IVCPU – Get Rating)'s stock price traded up 0.1% on Monday . The stock traded as high as $10.41 and last traded at $10.41. 451 shares were traded during mid-day t
Swiftmerge Acquisition (NASDAQ:IVCPU) Trading Up 5.3%
Swiftmerge Acquisition Corp. (NASDAQ:IVCPU – Get Rating)'s share price traded up 5.3% on Wednesday . The stock traded as high as $10.40 and last traded at $10.40. 601 shares were traded during tradin
Calamos Advisors LLC Purchases New Shares in Swiftmerge Acquisition Corp. (NASDAQ:IVCP)
Calamos Advisors LLC purchased a new stake in Swiftmerge Acquisition Corp. (NASDAQ:IVCP – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Excha
Parallax Volatility Advisers L.P. Invests $1.71 Million in Swiftmerge Acquisition Corp. (NASDAQ:IVCP)
Parallax Volatility Advisers L.P. acquired a new position in shares of Swiftmerge Acquisition Corp. (NASDAQ:IVCP – Get Rating) in the 3rd quarter, according to the company in its most recent disclosu
No Data